Amgen (AMGN) Acquisitions (2011 - 2022)
Amgen (AMGN) posted quarterly Acquisitions of $3.8 billion for Q4 2022, up 331.35% year-over-year from $890.0 million in Q4 2021, and up 331.35% quarter-over-quarter from $890.0 million in Q4 2021.
Amgen (AMGN) Acquisitions (2011 - 2022) Analysis & Trends
Amgen's Acquisitions history runs 10 years deep, the most recent figure standing at $3.8 billion for Q4 2022.
- In Q4 2022, Acquisitions rose 331.35% year-over-year to $3.8 billion; the TTM figure through Dec 2022 stood at $4.7 billion (up 425.14% YoY), while the FY2025 annual figure was $53.0 million, changed N/A from the prior year.
- Acquisitions for Q4 2022 stood at $3.8 billion, up from $890.0 million in the prior quarter.
- The five-year high for Acquisitions was $13.4 billion in Q4 2019, with the low at -$197.0 million in Q1 2018.
- The 4-year median for Acquisitions is $177.0 million (2019), against an average of $2.6 billion.
- The sharpest annual moves came in 2018 and 2019: Acquisitions sank 89.47% in 2018, then jumped 671900.0% in 2019.
- Amgen's Acquisitions stood at $2.0 million in 2018, then surged by 671900.0% to $13.4 billion in 2019, then slumped by 93.38% to $890.0 million in 2021, then jumped by 331.35% to $3.8 billion in 2022.
- Business Quant data shows AMGN's Acquisitions at $3.8 billion in Q4 2022, $890.0 million in Q4 2021, and $13.0 million in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | -17.24 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | - |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | - |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 11.21 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | - |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 3.84 Bn |
| Dec 31, 2021 | 890.00 Mn |
| Sep 30, 2021 | 13.00 Mn |
| Dec 31, 2019 | 13.44 Bn |
| Sep 30, 2019 | 177.00 Mn |
| Dec 31, 2018 | 2.00 Mn |
| Mar 31, 2018 | -197.00 Mn |
| Dec 31, 2017 | 19.00 Mn |
| Dec 31, 2015 | 359.00 Mn |
| Dec 31, 2014 | 50.00 Mn |
| Jun 30, 2014 | 11.00 Mn |
| Mar 31, 2014 | 104.00 Mn |
| Dec 31, 2013 | 9.43 Bn |
| Dec 31, 2012 | 400.00 Mn |
| Sep 30, 2012 | 319.00 Mn |
| Jun 30, 2012 | 702.00 Mn |
| Mar 31, 2012 | 969.00 Mn |
| Jun 30, 2011 | 298.00 Mn |
| Mar 31, 2011 | 403.00 Mn |